Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 PharmDx Receives European IVDR Certification
December 11, 2024
December 11, 2024
SANTA CLARA, California, Dec. 11 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release on Dec. 10, 2024:
Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IHC 28-8 pharmDx (Code SK005). This CDx assay has previously been CE-IVD-marked for sales in the European Union and is now certifi . . .
Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IHC 28-8 pharmDx (Code SK005). This CDx assay has previously been CE-IVD-marked for sales in the European Union and is now certifi . . .